NCT01487421 An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime Status COMPLETED Phase N/A
NCT01487369 Special Survey of Production of Insulin Aspart Specific Antibody Status COMPLETED Phase N/A
NCT01486966 Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes Status TERMINATED Phase PHASE4
NCT01486940 Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01486914 Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process Status COMPLETED Phase PHASE1
NCT01486901 Bioequivalence of Two Insulatard® Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01486888 Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01486875 Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes Status COMPLETED Phase N/A
NCT01486862 Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs Status COMPLETED Phase PHASE4
NCT01486381 Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01486290 Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study Status COMPLETED Phase NA
NCT01485913 A Randomized Trial of an Intensive Education Intervention Using a Network of Involved Diabetic Patients (Peer Educators) to Improve Glycemic Control of Type 2 Diabetic Patients Status COMPLETED Phase NA
NCT01484262 Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2 Status COMPLETED Phase N/A
NCT01480804 Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention Study Status COMPLETED Phase NA
NCT01480791 Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries Status WITHDRAWN Phase PHASE2